secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2021-12-21T23:59:59+00:00
Accession:  0001493152-21-032109
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics launches new $64.1M at-the-market equity offering
---------------------------------------------------------------------------

- Prior $25M ATM program terminated; $14.1M remained unsold.
- New ATM allows sale of up to $64,133,000 of common shares via Cantor Fitzgerald.
- Shares registered under May 2020 and March 2021 shelf registration statements.
- Legal opinion of Cooley LLP filed as Exhibit 5.1; proceeds not specified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315221032109/0001493152-21-032109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315221032109/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer